<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182019000200411</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v48n2.82718</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Effect of Lippia alba essential oil administration on obesity and T2DM markers in Wistar rats]]></article-title>
<article-title xml:lang="es"><![CDATA[Efecto de la administración del aceite esencial de Lippia alba sobre la obesidad y los marcadores T2DM en ratas wistar]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acevedo-Estupiñan]]></surname>
<given-names><![CDATA[Maria Victoria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[Elena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Sanabria]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Industrial de Santander  ]]></institution>
<addr-line><![CDATA[Bucaramanga Santander]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Industrial de Santander  ]]></institution>
<addr-line><![CDATA[Bucaramanga Santander]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Industrial de Santander  ]]></institution>
<addr-line><![CDATA[Bucaramanga Santander]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<volume>48</volume>
<numero>2</numero>
<fpage>411</fpage>
<lpage>424</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182019000200411&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182019000200411&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182019000200411&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Introduction: Lippia alba (Mill) N.E. Brown (Verbenaceae) is an aromatic plant from Central America, South America, and the Caribbean, it is traditionally used by the Colombian population to treat various diseases such as diabetes and hypertension. The purpose of this research was to evaluate the metabolic effects of Lippia alba essential oil (EO) oral administration on obesity and diabetes markers in Wistar rats.  Methods: control and Streptozotocin (STZ) diabetes induced rats were used to evaluate the EO metabolic effects. Glucose and triglycerides were measured using commercial colorimetric kits, the animals' weight was followed for 21 days treatment and TNF-&#945; and adiponectin concentration was determined with ELISA technique.  Results: The consumption of EO shows body weight gain regulation, lower glucose and cholesterol levels in normal rats and lower TNF- &#945; in comparison with the Glibenclamide treated rats between the STZ diabetic groups. No toxic effects were founded.  Conclusions: The EO exerts a benefical metabolic effect in rats, therefore it is interesting to be evaluate a future in human beings with T2DM or overweight.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: Lippia alba (Mill) N.E. Brown (Verbenaceae) más conocida como pronto alivio, es una planta aromática de Centro, Sur América y el Caribe que se utiliza tradicionalmente en Colombia para el tratamiento de diversas enfermedades, como la diabetes e hipertensión. El objetivo del trabajo fue evaluar el efecto metabólico del aceite esencial de Lippia alba (Mill), administrado oralmente, sobre moléculas relacionadas con obesidad y diabetes en ratas Wistar.  Métodos: Se pesaron los animales diariamente. Después de 21 días de tratamiento con el AE se determinó en plasma la glucosa, triglicéridos con kits comerciales y las adipocitoquinas (adiponectina y factor de necrosis tumoral alfa (TNF&#945;) marcadores de resistencia a la acción de la insulina) por la técnica de ELISA.  Resultados: El consumo de AE mostró una regulación en la ganancia de peso corporal y disminución en los niveles de glucosa y triglicéridos en los animales normales que recibieron el AE. Dentro de los grupos con diabetes inducida, el grupo tratado con AE mostró menores valores de TNF-&#945; comparado con el grupo tratado con glibenclamida.  Conclusiones: El AE ejerce un efecto benéfico en el metabolismo de los animales, por lo tanto, es interesante para ser evaluado en seres humanos con diabetes o sobrepeso.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Cytokines]]></kwd>
<kwd lng="en"><![CDATA[essential oil]]></kwd>
<kwd lng="en"><![CDATA[Lippia alba]]></kwd>
<kwd lng="en"><![CDATA[metabolism]]></kwd>
<kwd lng="en"><![CDATA[obesity]]></kwd>
<kwd lng="en"><![CDATA[type 2 diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[Metabolismo]]></kwd>
<kwd lng="es"><![CDATA[aceite esencial]]></kwd>
<kwd lng="es"><![CDATA[Lippia alba]]></kwd>
<kwd lng="es"><![CDATA[adipocitoquinas]]></kwd>
<kwd lng="es"><![CDATA[obesidad]]></kwd>
<kwd lng="es"><![CDATA[DMT2]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hotamisligil]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammation, metaflammation and immunometabolic disorders]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2017</year>
<volume>542</volume>
<numero>7640</numero>
<issue>7640</issue>
<page-range>177-85</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lane]]></surname>
<given-names><![CDATA[M.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[Q.Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[M.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation]]></article-title>
<source><![CDATA[Biochem. Biophys. Res. Commun]]></source>
<year>1999</year>
<volume>266</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>677-83</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wellen]]></surname>
<given-names><![CDATA[K.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hotamisligil]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammation, stress, and diabetes]]></article-title>
<source><![CDATA[J. Clin. Invest]]></source>
<year>2005</year>
<volume>115</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1111-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hennebelle]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sahpaz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Joseph]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bailleul]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethnopharmacology of Lippia alba]]></article-title>
<source><![CDATA[J. Ethnopharmacol]]></source>
<year>2008</year>
<volume>116</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>211-22</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ospina]]></surname>
<given-names><![CDATA[L.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Pinzón-Serrano]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plantas usadas como antidiabéticas en la medicina popular colombiana]]></article-title>
<source><![CDATA[Rev. Colomb. Cienc. Quím. Farm]]></source>
<year>1995</year>
<volume>23</volume>
<page-range>81-94</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pascual]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Slowing]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Carretero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Mata]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Villar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lippia: traditional uses, chemistry and pharmacology: A review]]></article-title>
<source><![CDATA[J. Ethnopharmacol]]></source>
<year>2001</year>
<volume>76</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>201-14</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hatano]]></surname>
<given-names><![CDATA[V.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Torricelli]]></surname>
<given-names><![CDATA[A.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Giassi]]></surname>
<given-names><![CDATA[A.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Coslope]]></surname>
<given-names><![CDATA[L.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Viana]]></surname>
<given-names><![CDATA[M.B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anxiolytic effects of repeated treatment with an essential oil from Lippia alba and (R)-(-)-carvone in the elevated T-maze]]></article-title>
<source><![CDATA[Braz. J. Med. Biol. Res]]></source>
<year>2012</year>
<volume>45</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>238-43</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mesa-Arango]]></surname>
<given-names><![CDATA[A.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Montiel-Ramos]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Durán]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Betancur-Galvis]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E. Brown: Composition, cytotoxicity and antifungal activity]]></article-title>
<source><![CDATA[Mem. Inst. Oswaldo Cruz]]></source>
<year>2009</year>
<volume>104</volume>
<page-range>878-84</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[E.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Jaramillo]]></surname>
<given-names><![CDATA[B.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparación de la composición química y de la actividad antioxidante in vitro de los metabolitos secundarios volátiles de plantas de la familia verbenaceae]]></article-title>
<source><![CDATA[Rev. Acad. Colomb. Cienc]]></source>
<year>2003</year>
<volume>27</volume>
<numero>105</numero>
<issue>105</issue>
<page-range>579-98</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vale]]></surname>
<given-names><![CDATA[T.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[F.J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[T.C.M. De]]></given-names>
</name>
<name>
<surname><![CDATA[Viana]]></surname>
<given-names><![CDATA[G.S.B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Behavioral effects of essential oils from Lippia alba (Mill.) N.E. Brown chemotypes]]></article-title>
<source><![CDATA[J. Ethnopharmacol]]></source>
<year>1999</year>
<volume>167</volume>
<page-range>127-33</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta-García]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesidad, tejido adiposo y resistencia a la insulina]]></article-title>
<source><![CDATA[Acta Bioquím. Clín. Latinoam]]></source>
<year>2012</year>
<volume>46</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>183-94</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ohashi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Shibata]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Murohara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ouchi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of anti-inflammatory adipokines in obesity-related diseases]]></article-title>
<source><![CDATA[Trends Endocrinol. Metab]]></source>
<year>2014</year>
<volume>25</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>348-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<source><![CDATA[Directiva 2010/63/UE del Parlamento Europeo y del Consejo de 22 de septiembre de 2010 relativa a la protección de los animales utilizados para fines científicos, Diario Oficial de la Unión Europea, L 276]]></source>
<year></year>
<page-range>33-79</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>OECD</collab>
<source><![CDATA[Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure, OECD Guidelines for the Testing of Chemicals, Section 4]]></source>
<year>2008</year>
<page-range>1-27</page-range><publisher-loc><![CDATA[Paris ]]></publisher-loc>
<publisher-name><![CDATA[OECD Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hemalatha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wahi]]></surname>
<given-names><![CDATA[A.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[P.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Chansouria]]></surname>
<given-names><![CDATA[J.P.N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypoglycemic activity of Withania coagulans Dunal in streptozotocin induced diabetic rats]]></article-title>
<source><![CDATA[J. Ethnopharmacol]]></source>
<year>2004</year>
<volume>93</volume>
<page-range>261-4</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lenzen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The mechanisms of alloxan- and streptozotocin-induced diabetes]]></article-title>
<source><![CDATA[Diabetologia]]></source>
<year>2008</year>
<volume>51</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>216-26</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olivero-Verbel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero-Castilla]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxicity of the essential oil of the cytral chemotype of Lippia alba (Mill.) N.E. Brown]]></article-title>
<source><![CDATA[Acta Toxicol. Argent]]></source>
<year>2010</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Srinivasan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ramarao]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Animal models in type 2 diabetes research: An overview]]></article-title>
<source><![CDATA[Indian J. Med. Res]]></source>
<year>2007</year>
<volume>125</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>451-72</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Scribner]]></surname>
<given-names><![CDATA[K.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery]]></article-title>
<source><![CDATA[Diabetes Obes. Metab]]></source>
<year>1999</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>75-86</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Junod]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[A.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Stauffacher]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Renold]]></surname>
<given-names><![CDATA[A.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetogenic action of streptozotocin: relationship of dose to metabolic response]]></article-title>
<source><![CDATA[J. Clin. Invest]]></source>
<year>1969</year>
<volume>48</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2129-39</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Martín]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zurita-Molina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Transaminasas: valoración y significación clínica, Protocolos diagnóstico-terapéuticos de gastroenterología, hepatología y nutrición pediátrica]]></source>
<year>2010</year>
<page-range>267-75</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Asociación Española de Pediatría]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asnaashari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Delazar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Habibi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Vasfi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Nahar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hamedeyazdan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Essential oil from Citrus aurantifolia prevents ketotifen-induced weight-gain in mice]]></article-title>
<source><![CDATA[Phyther. Res]]></source>
<year>2010</year>
<volume>24</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1893-7</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Najafian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A review of alpha-amylase inhibitors on weight loss and glycemic control in pathological state such as obesity and diabetes]]></article-title>
<source><![CDATA[Comp. Clin. Path]]></source>
<year>2014</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1253-64</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Najafian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ebrahim-Habibi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yaghmaei]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Parivar]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Larijani]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Citral as a potential antihyperlipidemic medicine in diabetes: A study on streptozotocin-induced diabetic rats]]></article-title>
<source><![CDATA[Iran. J. Diabetes Lipid Disord]]></source>
<year>2011</year>
<volume>10</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gil-Campos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cañete]]></surname>
<given-names><![CDATA[R.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adiponectin, the missing link in insulin resistance and obesity]]></article-title>
<source><![CDATA[Clin. Nutr]]></source>
<year>2004</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>963-74</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerre-Millo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adiponectin: An update]]></article-title>
<source><![CDATA[Diabetes Metab]]></source>
<year>2008</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-8</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maury]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Brichard]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome]]></article-title>
<source><![CDATA[Mol. Cell. Endocrinol]]></source>
<year>2010</year>
<volume>314</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-16</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nieto-Vazquez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Veledo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kramer]]></surname>
<given-names><![CDATA[D.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Vila-Bedmar]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Guerra]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin resistance associated to obesity: The link TNF-alpha]]></article-title>
<source><![CDATA[Arch. Physiol. Biochem]]></source>
<year>2008</year>
<volume>114</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>183-94</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mirza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hossain]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mathews]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pino]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gay]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: A cross-sectional study]]></article-title>
<source><![CDATA[Cytokine]]></source>
<year>2012</year>
<volume>57</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>136-42</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
